Kiromic Biopharma Probability of Future Stock Price Finishing Under 2.75
| KRBPDelisted Stock | USD 2.68 0.07 2.55% |
Kiromic |
Kiromic Biopharma Target Price Odds to finish below 2.75
The tendency of Kiromic Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 2.75 after 90 days |
| 2.68 | 90 days | 2.75 | about 14.39 |
Based on a normal probability distribution, the odds of Kiromic Biopharma to stay under $ 2.75 after 90 days from now is about 14.39 (This Kiromic Biopharma probability density function shows the probability of Kiromic Stock to fall within a particular range of prices over 90 days) . Probability of Kiromic Biopharma price to stay between its current price of $ 2.68 and $ 2.75 at the end of the 90-day period is roughly 2.28 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.76 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Kiromic Biopharma will likely underperform. Additionally Kiromic Biopharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Kiromic Biopharma Price Density |
| Price |
Predictive Modules for Kiromic Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kiromic Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kiromic Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Kiromic Biopharma is not an exception. The market had few large corrections towards the Kiromic Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kiromic Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kiromic Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.4 | |
β | Beta against Dow Jones | 1.76 | |
σ | Overall volatility | 0.66 | |
Ir | Information ratio | -0.03 |
Kiromic Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kiromic Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kiromic Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kiromic Biopharma is not yet fully synchronised with the market data | |
| Kiromic Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kiromic Biopharma currently holds about 6.51 M in cash with (23.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Roughly 68.0% of the company shares are owned by institutional investors |
Kiromic Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kiromic Stock often depends not only on the future outlook of the current and potential Kiromic Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kiromic Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 544.5 K | |
| Cash And Short Term Investments | 645.2 K |
Kiromic Biopharma Technical Analysis
Kiromic Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Kiromic Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kiromic Biopharma. In general, you should focus on analyzing Kiromic Stock price patterns and their correlations with different microeconomic environments and drivers.
Kiromic Biopharma Predictive Forecast Models
Kiromic Biopharma's time-series forecasting models is one of many Kiromic Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kiromic Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Kiromic Biopharma
Checking the ongoing alerts about Kiromic Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kiromic Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Kiromic Biopharma is not yet fully synchronised with the market data | |
| Kiromic Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kiromic Biopharma currently holds about 6.51 M in cash with (23.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Roughly 68.0% of the company shares are owned by institutional investors |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |